Michael W. Young
-
Forward thinking and innovative Life Sciences Vice President with Award-Winning marketing and business development credentials and over a decade of Patient-Advocacy Board of Director-level experience.
-
Comprehensive experience as a biotech and pharma commercialization leader, with extensive success in the development and implementation of strategic marketing and clinical development strategies.
-
Recognized as a Strategic Alliance Management expert who effectively identifies and capitalizes on business and relationship opportunities and trends, transforming them into actions, solutions, and revenue.
-
Proven ability to utilize entrepreneurial management style to mentor and develop collaborative, cross-functional teams. ​
Affiliations
-
Cutaneous Lymphoma Foundation – Board of Directors (President 2011 and Industry Director since 2000)
-
​San Diego BIOCOM – CRO Committee, CRO Marketing Subcommittee (2013-14 Executive Steering group)
-
Association of Strategic Alliance Professionals (ASAP) BioPharma Council (2013 Biopharma Conference Program Committee)
-
CLINICAL LEADER.com - Editorial Advisory Board Member
-
​Sino-American Biotechnology & Pharmaceutical Association (SABPA) ​(External Relations Committee)
-
United States Cutaneous Lymphoma Consortium (USCLC) (Committee Member)
-
International Society of Cutaneous Lymphoma (ISCL)​
-
Association of Clinical Research Organizations (ACRO)
-
Former President, Medical Marketing Association​
Awards
-
International Society of Cutaneous Lymphoma (ISCL) Award of Merit (For support and guidance above and beyond all other industry partners)
-
US Medical Marketer of the Year – Medical Marketing Association
-
Ligand Pharmaceuticals Management Committee Leadership Award (For successful launch of 4-product development franchise)
-
Ligand Pharmaceuticals Management Committee Leadership Award (For European launch of company franchise)
-
Ligand Pharmaceuticals Outstanding Achievement Award (For development and implementation of KOL education program)
-
Cutaneous Lymphoma Foundation Recognition Award (For a Decade of Service)
Receiving ISCL Recognition from Elise Olsen, MD, Director of the Duke Dermatopathology Center, Duke University Medical Center.
Selected Publications & Presentations
PUBLICATIONS
-
​Young, M.W., Woolston, T.L., Supp, A.P. SCRIP CLINICAL RESEARCH: "Integrating Clinical Development and Central Labs for Optimised Trial Delivery", Scrip Clinical Research, 28-30 (October 10, 2012).
-
Young, M.W., Laviertes, J. STRATEGIC ALLIANCE Magazine: "Build, Buy, or Ally? Alliance Management at the Forefront of Service-Based Alliances" Strategic Alliance Magazine; Association of Strategic Alliance Professionals, ASAP Media, #6, 15-17, 55 (August 27, 2012)
-
​Young, M.W. et al (Contributing Expert) PATIENT ADVOCACY MANUAL: A Patient's Guide to Understanding Cutaneous Lymphoma: A Comprehensive Guide, The Cutaneous Lymphoma Foundation (May 22, 2012).
PRESENTATIONS
-
10th Annual Strategic Alliance Management Congress, May 2013, Philadelphia, PA, Co-Speaker: "Service-Based Alliances in the Life Sciences Industry: Are You Getting Accretive Value from Collaboration?"
-
Cutaneous Lymphoma Foundation - Patient Education Forum, Nov 2012, Detroit, MI, Speaker: "New Therapy Development"
-
Association of Strategic Alliance Professionals BioPharm Conference, June 2011, New Brunswick, NJ, Speaker: Alliance Managers as Diplomats - "Diplomacy & Boundary Navigation - A Complex Competency Alliance Managers Must Master"
-
​3rd Annual Forum on Oncology Commercialization Strategies, Jan 2010, Philadelphia, PA, Co-Speaker: "Preparing for Successful Interactions with the Oncology Drug Advisory Committee (ODAC)"